Suppr超能文献

功能蛋白质组学分析揭示了 PKCδ 在调节细胞存活和细胞死亡中的作用:对癌症发病机制和治疗的影响。

Functional proteomic analysis reveals roles for PKCδ in regulation of cell survival and cell death: Implications for cancer pathogenesis and therapy.

机构信息

Department of Craniofacial Biology, School of Dental Medicine, USA.

Department of Pharmacology, School of Medicine, USA.

出版信息

Adv Biol Regul. 2020 Dec;78:100757. doi: 10.1016/j.jbior.2020.100757. Epub 2020 Sep 28.

Abstract

Protein Kinase C-δ (PKCδ), regulates a broad group of biological functions and disease processes, including well-defined roles in immune function, cell survival and apoptosis. PKCδ primarily regulates apoptosis in normal tissues and non-transformed cells, and genetic disruption of the PRKCD gene in mice is protective in many diseases and tissue damage models. However pro-survival/pro-proliferative functions have also been described in some transformed cells and in mouse models of cancer. Recent evidence suggests that the contribution of PKCδ to specific cancers may depend in part on the oncogenic context of the tumor, consistent with its paradoxical role in cell survival and cell death. Here we will discuss what is currently known about biological functions of PKCδ and potential paradigms for PKCδ function in cancer. To further understand mechanisms of regulation by PKCδ, and to gain insight into the plasticity of PKCδ signaling, we have used functional proteomics to identify pathways that are dependent on PKCδ. Understanding how these distinct functions of PKCδ are regulated will be critical for the logical design of therapeutics to target this pathway.

摘要

蛋白激酶 C-δ(PKCδ)调节广泛的生物学功能和疾病过程,包括在免疫功能、细胞存活和凋亡方面的明确作用。PKCδ 在正常组织和非转化细胞中主要调节细胞凋亡,并且在许多疾病和组织损伤模型中,PRKCD 基因的遗传破坏具有保护作用。然而,在一些转化细胞和癌症的小鼠模型中也描述了促生存/促增殖功能。最近的证据表明,PKCδ 对特定癌症的贡献可能部分取决于肿瘤的致癌背景,这与其在细胞存活和细胞死亡中的矛盾作用一致。在这里,我们将讨论目前已知的 PKCδ 的生物学功能以及 PKCδ 在癌症中的潜在功能范例。为了进一步了解 PKCδ 的调节机制,并深入了解 PKCδ 信号的可塑性,我们使用功能蛋白质组学来鉴定依赖于 PKCδ 的途径。了解这些不同的 PKCδ 功能是如何被调节的,对于逻辑设计针对该途径的治疗方法至关重要。

相似文献

2
Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease.
Pharmacol Ther. 2016 Sep;165:1-13. doi: 10.1016/j.pharmthera.2016.05.001. Epub 2016 May 11.
4
Two faces of protein kinase Cδ: the contrasting roles of PKCδ in cell survival and cell death.
ScientificWorldJournal. 2010 Nov 16;10:2272-84. doi: 10.1100/tsw.2010.214.
5
Crosstalk between tumor suppressors p53 and PKCδ: Execution of the intrinsic apoptotic pathways.
Cancer Lett. 2016 Jul 28;377(2):158-63. doi: 10.1016/j.canlet.2016.04.032. Epub 2016 Apr 26.
6
Protein kinase C delta is required for survival of cells expressing activated p21RAS.
J Biol Chem. 2007 May 4;282(18):13199-210. doi: 10.1074/jbc.M610225200. Epub 2007 Mar 8.
8
Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway.
J Biol Chem. 2009 Nov 27;284(48):33456-65. doi: 10.1074/jbc.M109.036186. Epub 2009 Oct 15.
9
PKCdelta signaling: mechanisms of DNA damage response and apoptosis.
Cell Signal. 2007 May;19(5):892-901. doi: 10.1016/j.cellsig.2007.01.027. Epub 2007 Feb 7.

引用本文的文献

3
A Multimodel Study of the Role of Novel PKC Isoforms in the DNA Integrity Checkpoint.
Int J Mol Sci. 2023 Oct 31;24(21):15796. doi: 10.3390/ijms242115796.
4
Microgravity and immune cells.
J R Soc Interface. 2023 Feb;20(199):20220869. doi: 10.1098/rsif.2022.0869. Epub 2023 Feb 15.
5
Hippo signaling and histone methylation control cardiomyocyte cell cycle re-entry through distinct transcriptional pathways.
PLoS One. 2023 Feb 13;18(2):e0281610. doi: 10.1371/journal.pone.0281610. eCollection 2023.
6
The CWI Pathway: A Versatile Toolbox to Arrest Cell-Cycle Progression.
J Fungi (Basel). 2021 Dec 4;7(12):1041. doi: 10.3390/jof7121041.

本文引用的文献

1
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma.
Br J Cancer. 2023 Apr;128(6):1040-1051. doi: 10.1038/s41416-022-02133-6. Epub 2023 Jan 9.
2
Suspension of marketing authorization for ingenol mebutate.
Br J Dermatol. 2020 Oct;183(4):792. doi: 10.1111/bjd.19330. Epub 2020 Jul 27.
3
Conditional Knockout of PKC-δ in Osteoclasts Favors Bone Mass Accrual in Males Due to Decreased Osteoclast Function.
Front Cell Dev Biol. 2020 Jun 9;8:450. doi: 10.3389/fcell.2020.00450. eCollection 2020.
5
Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy.
Nat Commun. 2020 Apr 20;11(1):1879. doi: 10.1038/s41467-020-15742-7.
6
Targeting apoptosis in cancer therapy.
Nat Rev Clin Oncol. 2020 Jul;17(7):395-417. doi: 10.1038/s41571-020-0341-y. Epub 2020 Mar 23.
7
Lineage plasticity in cancer: a shared pathway of therapeutic resistance.
Nat Rev Clin Oncol. 2020 Jun;17(6):360-371. doi: 10.1038/s41571-020-0340-z. Epub 2020 Mar 9.
10
Discovery of Small Molecules for the Reversal of T Cell Exhaustion.
Cell Rep. 2019 Dec 3;29(10):3293-3302.e3. doi: 10.1016/j.celrep.2019.10.119.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验